美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
ADZENYS XR-ODT	204326	001	NDA	AMPHETAMINE	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	EQ 3.1MG BASE	Yes	No	2016/01/27	2016/01/27	NEOS THERAPS	Prescription
ADZENYS XR-ODT	204326	002	NDA	AMPHETAMINE	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	EQ 6.3MG BASE	Yes	No	2016/01/27	2016/01/27	NEOS THERAPS	Prescription
ADZENYS XR-ODT	204326	003	NDA	AMPHETAMINE	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	EQ 9.4MG BASE	Yes	No	2016/01/27	2016/01/27	NEOS THERAPS	Prescription
ADZENYS XR-ODT	204326	004	NDA	AMPHETAMINE	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	EQ 12.5MG BASE	Yes	No	2016/01/27	2016/01/27	NEOS THERAPS	Prescription
ADZENYS XR-ODT	204326	005	NDA	AMPHETAMINE	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	EQ 15.7MG BASE	Yes	No	2016/01/27	2016/01/27	NEOS THERAPS	Prescription
ADZENYS XR-ODT	204326	006	NDA	AMPHETAMINE	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	EQ 18.8MG BASE	Yes	Yes	2016/01/27	2016/01/27	NEOS THERAPS	Prescription